Search
for
Sort by
Research 361–390 of 488
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- JAK Inhibitors for Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Dietary Habits in Japanese Patients with Alopecia Areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Refractory Myasthenia Gravis and Concurrent Alopecia Areata Postthymectomy With Improvements After Cortisone Taper: A Case Report
- Upadacitinib for the treatment of alopecia areata – A case report